Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Papaporfyriou, P. Bakakos, K. Kostikas, G. Papatheodorou, G. Hillas, E. Konstantelou, N. Koulouris, S. Papiris, S. Loukides (Athens, Greece). Activin –A and follistatin in sputum supernatant and BAL in patients with asthma. Eur Respir J 2013; 42: Suppl. 57, 832

Member's Comments

No comment yet.

Related content which might interest you: Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Periostin in lower airway samples and serum, a novel asthma marker? Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Serum periostin but not airway POSTN expression is reduced in smokers with asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Assessment of ATP degradation in bronchoalveolar lavage fluid Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014